Overview

Neoadjuvant Itraconazole in Non-small Cell Lung Cancer

Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacodynamics effects of itraconazole in early-stage non-small cell lung cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
United States Department of Defense
Treatments:
Hydroxyitraconazole
Itraconazole